Pharmaceutical research teams successfully utilized the cell-free synthetic biology method to formulate personalized cancer immunotherapies tailored to patient-specific neoantigen profiles within two weeks of biopsy sequencing.
Oncologists described the rapid turnaround capability as a transformative development for precision oncology, where treatment timing is critical for patient outcomes.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.news2026.example.com/vaccine-tech-34